These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37396298)

  • 1. Quality Variations in Thyrotropin Alfa.
    Isaacs JT; Almeter PJ; Henderson BS; Hunter AN; Platt TL; Samano-Garcia C; Lodder RA
    Contact Context; 2023; 2023():. PubMed ID: 37396298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spectrometric Analysis of Process Variations in Remifentanil.
    Isaacs JT; Almeter PJ; Henderson BS; Hunter AN; Platt TL; Lodder RA
    Contact Context; 2022; 2022():. PubMed ID: 36187755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential Process Control Issues with Pemetrexed.
    Isaacs JT; Almeter PJ; Henderson BS; Hunter AN; Platt TL; Lodder RA
    Contact Context; 2022; 2022():. PubMed ID: 35967958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spectrometric Results of Process Variations in Dacarbazine.
    Isaacs JT; Almeter PJ; Henderson BS; Hunter AN; Platt TL; Lodder RA
    Contact Context; 2022; 2022():. PubMed ID: 35035310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human thyroid stimulating hormone in 2008: focus on thyroid cancer management.
    Gramza A; Schuff KG
    Onco Targets Ther; 2009 Jan; 1():87-101. PubMed ID: 21127756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variability in Content of Piperacillin and Tazobactam Injection.
    Isaacs JT; Almeter PJ; Henderson BS; Hunter AN; Platt TL; Lodder RA
    Contact Context; 2022; 2022():. PubMed ID: 35506061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human thyroid-stimulating hormone: pharmacology, clinical applications and potential uses.
    Emerson CH; Torres MS
    BioDrugs; 2003; 17(1):19-38. PubMed ID: 12534318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levothyroxine Variations by Process Analytical Technology.
    Isaacs JT; Almeter PJ; Henderson BS; Hunter AN; Platt TL; Lodder RA
    Contact Context; 2022; 2022():. PubMed ID: 35440917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectral Intra-Lot and Inter-Lot Variability in Carfilzomib.
    Isaacs JT; Almeter PJ; Henderson BS; Hunter AN; Platt TL; Anwar H; Lodder RA
    Contact Context; 2023; 2023():. PubMed ID: 37008539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intra-Lot and Inter-Lot Variability in Cosyntropin.
    Almeter PJ; Isaacs JT; Hunter AN; Henderson BS; Lodder RA
    Contact Context; 2021; 2021():. PubMed ID: 35035309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does recombinant human thyrotropin-stimulated positron emission tomography with [18F]fluoro-2-deoxy-D-glucose improve detection of recurrence of well-differentiated thyroid carcinoma in patients with low serum thyroglobulin?
    Vera P; Kuhn-Lansoy C; Edet-Sanson A; Hapdey S; Modzelewski R; Hitzel A; d'Anjou J; Basuyau JP
    Thyroid; 2010 Jan; 20(1):15-23. PubMed ID: 20017617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FTNIR Spectrometry of Micafungin Sodium Quality.
    Isaacs JT; Almeter PJ; Henderson BS; Hunter AN; Platt TL; Lodder RA
    Contact Context; 2022; 2022():. PubMed ID: 35360460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of day 3 and day 5 thyroglobulin results after thyrogen injection in differentiated thyroid cancer patients.
    Sager S; Hatipoglu E; Gunes B; Asa S; Uslu L; Sönmezoğlu K
    Ther Adv Endocrinol Metab; 2018 Jun; 9(6):177-183. PubMed ID: 29854387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of preablation stimulated thyroglobulin and thyroglobulin/thyroid-stimulating hormone ratio in differentiated thyroid cancer.
    Lin Y; Li T; Liang J; Li X; Qiu L; Wang S; Chen Y; Kang Z; Li F
    Clin Nucl Med; 2011 Dec; 36(12):1102-5. PubMed ID: 22064080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroglobulin Changes are Highly Dependent on TSH in Low-risk DTC Patients not Treated with Radioiodine.
    Matrone A; Faranda A; Latrofa F; Gambale C; Stefani Donati D; Molinaro E; Agate L; Viola D; Piaggi P; Torregrossa L; Basolo F; Elisei R
    J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32453405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of recombinant thyroid-stimulating hormone (rhTSH) in the detection and management of well-differentiated thyroid carcinoma: a roundtable discussion.
    Schlumberger MJ; Incerti C; Pacini F; Reiners C
    J Endocrinol Invest; 1999; 22(11 Suppl):35-41. PubMed ID: 10727004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant human thyrotropin is helpful in the follow-up and 131I therapy of patients with thyroid cancer: a report of the results and benefits using recombinant human thyrotropin in clinical routine.
    Kohlfuerst S; Igerc I; Lind P
    Thyroid; 2005 Apr; 15(4):371-6. PubMed ID: 15876162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using recombinant human TSH in the management of well-differentiated thyroid cancer: current strategies and future directions.
    Mazzaferri EL; Kloos RT
    Thyroid; 2000 Sep; 10(9):767-78. PubMed ID: 11041454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intra-Lot and Inter-Lot Variability in Ceftaroline Fosamil.
    Almeter PJ; Isaacs JT; Hunter AN; Henderson BS; Lodder RA
    Contact Context; 2021; 2021():. PubMed ID: 35360663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant human thyrotropin in follow-up of patients with differentiated thyroid cancer.
    Podoba J
    Bratisl Lek Listy; 2010; 111(1):38-40. PubMed ID: 20429310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.